Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05428176 · ClinicalTrials.gov registry record · NA

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

A NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia, sponsored by City of Hope Medical Center.

Active
Registry status
NA
Development phase
342
Enrollment target
4
Study locations

NCT05428176: Active NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia, sponsored by City of Hope Medical Center.

NCT05428176 is a NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 342 participants, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (197% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05428176, a NA study of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
342 participants
Enrollment target
4
Study locations

Study Summary

This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. Most children with leukemia and lymphoblastic lymphoma can be cured due to advancements in diagnosis and treatment. However, because treatments for these conditions target the central nervous system, these children are at increased risk for developing neurocognitive late effects (problems with attention, thinking, learning, and remembering). Fortunately, many survivors do well, but some children continue to struggle with learning and have academic difficulties after their cancer treatments. The purpose of this research study is to see whether providing parents with educational knowledge and parenting tips using videoconferencing and a special website better helps their cancer survivor child in learning and school achievement compared to typical services.

Primary Outcome

Measured using the Wechsler Individual Achievement Test (WIAT) Numerical Operations (NO) subset. The WIAT NO score at 1 year will be compared between treatment arms using the Generalized Estimating Equation (GEE), adjusting for baseline values and accounting for correlations among patients within a study site. An indicator variable for treatment arm will be included in the model, its significance tested, and a 95% confidence interval constructed.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • OTHER Internet-Based Intervention

Study Locations (4)

California

  • City of Hope Medical Center - Duarte
  • Childrens Hospital of Los Angeles - Los Angeles
  • Rady Children's Hospital San Diego - San Diego
  • University of Calif San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 342 participants
Start Date 2023-02-16
Est. Completion 2027-06-30
Phase NA
City of Hope Medical Center

582 total trials

What the registry record for NCT05428176 still lists

NCT05428176 is an interventional study that assigns participants to a tested intervention. The registered 342 participants enrollment target is mid-sized for trials with a published cap, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (197% higher).

The record links to 4 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.

NCT05428176 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05428176 about?

NCT05428176 is a clinical study titled "A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors". This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. Most children with leukemia and lymphoblastic lymphoma can be cured due to advancements in diagnosis and treatment. However, because treatments f...

What is the current status of trial NCT05428176?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 342 participants. The study started on 2023-02-16. Estimated completion is 2027-06-30.

What conditions does trial NCT05428176 study?

This clinical trial studies the following conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Leukemia, Lymphoblastic Lymphoma.

What interventions are being tested in trial NCT05428176?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Internet-Based Intervention (OTHER).

Who is sponsoring clinical trial NCT05428176?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05428176 being conducted?

This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Myeloid Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05428176's enrollment target sits among peer trials

342 17th of 306 higher than 290 of 306 other Acute Myeloid Leukemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acute Myeloid Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05283850 · 342 participants · Phase 2

    Surviving PEA in Roanoke (SPEAR) Study

  • NCT05714085 · 342 participants · Phase 2

    Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  • NCT06188702 · 342 participants · Phase 1

    S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

  • NCT06544941 · 342 participants · NA

    Improving Maternal Sleep and Mental Health

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05428176, the US trial registry maintained by the National Library of Medicine. NCT05428176 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.